Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Dr. David Mason is a staff surgeon in the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery. He holds joint appointments as a staff surgeon in the Clinic's Transplantation Center in the Division of Surgery and in the Cleveland Clinic Cancer Center. He specializes in general thoracic surgery . He has a particular interest in minimally invasive surgery including robotic surgery, thoracoscopic and laparoscopic surgery. His clinical interests include lung cancer, esophageal cancer, malignant mesothelioma, lung volume reduction surgery, myasthenia gravis, antireflux surgery, hyperhidrosis, and lung transplantation. He has research interests in all of these areas. Dr. Mason is board certified in general and thoracic surgery.
Following an undergraduate degree from Harvard University, Dr. Mason received his medical degree from Columbia College of Physicians & Surgeons in New York. He did his internship and residency in general surgery as well as his Thoracic Surgery fellowship at the Brigham and Women's Hospital in Boston. He completed a research fellowship at the University of Washington in Seattle. Dr. Mason has held academic appointments at Johns Hopkins Hospital in Baltimore as Assistant Professor of Thoracic Surgery
Dr. Mason was appointed in 2004 as a staff surgeon in the Cleveland Clinic Heart and Vascular Institute, Transplantation Center and Cancer Institute.
He has authored or co-authored multiple chapters in medical textbooks on his specialty interests including minimally invasive surgery, video asssisted thoracoscopic (VATS) lobectomy, antireflux surgery, multimodality treatment of lung cancer and esophageal cancer. He has published extensively in leading publications such as the Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Journal of Thoracic Oncology, Circulation, Journal of Heart and Lung Transplantation, and Transplantation.
Dr. Mason is a member of The American Association for Thoracic Surgery, Society of Thoracic Surgeons, the International Society of Heart and Lung Transplantation , American College of Surgeons, American Society of Transplant Surgeons and the American College of Chest Physicians.
Lung cancer, esophageal cancer, malignant mesothelioma, lung volume reduction surgery, myasthenia gravis, antireflux surgery, hyperhidrosis, lung transplantation
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/8/2013, Dr. Mason has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.